<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Masocha W</submitter><funding>Kuwait University</funding><pagination>1545</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11274467</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>12(7)</volume><pubmed_abstract>The use of paclitaxel as a chemotherapeutic drug is limited by the development of dose-dependent paclitaxel-induced neuropathic pain (PINP). Recently, we observed that the combination of indomethacin plus minocycline (IPM) attenuates PINP in a mouse model in a cannabinoid (CB) receptor-dependent manner. Indomethacin inhibits cyclooxygenase (COX) activity, and minocycline inhibits 5-lipoxygenase (5-LOX) activity. Male Sprague Dawley rats with paclitaxel-induced mechanical allodynia were treated with indomethacin, minocycline, IPM combination, licofelone (a dual COX/LOX inhibitor), or their vehicles. AM251, a CB1 receptor antagonist, and AM630, a CB2 receptor antagonist, were administered before the IPM combination or licofelone. Mechanical allodynia was measured using a dynamic plantar aest</pubmed_abstract><journal>Biomedicines</journal><pubmed_title>Licofelone, a Dual COX/LOX Inhibitor, Ameliorates Paclitaxel-Induced Mechanical Allodynia in Rats in a Cannabinoid Receptor-Dependent Manner.</pubmed_title><pmcid>PMC11274467</pmcid><funding_grant_id>PT02/21</funding_grant_id><pubmed_authors>Masocha W</pubmed_authors><pubmed_authors>Aly E</pubmed_authors><pubmed_authors>Albaloushi A</pubmed_authors><pubmed_authors>Al-Romaiyan A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Licofelone, a Dual COX/LOX Inhibitor, Ameliorates Paclitaxel-Induced Mechanical Allodynia in Rats in a Cannabinoid Receptor-Dependent Manner.</name><description>The use of paclitaxel as a chemotherapeutic drug is limited by the development of dose-dependent paclitaxel-induced neuropathic pain (PINP). Recently, we observed that the combination of indomethacin plus minocycline (IPM) attenuates PINP in a mouse model in a cannabinoid (CB) receptor-dependent manner. Indomethacin inhibits cyclooxygenase (COX) activity, and minocycline inhibits 5-lipoxygenase (5-LOX) activity. Male Sprague Dawley rats with paclitaxel-induced mechanical allodynia were treated with indomethacin, minocycline, IPM combination, licofelone (a dual COX/LOX inhibitor), or their vehicles. AM251, a CB1 receptor antagonist, and AM630, a CB2 receptor antagonist, were administered before the IPM combination or licofelone. Mechanical allodynia was measured using a dynamic plantar aest</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Jul</publication><modification>2026-04-08T19:21:29.673Z</modification><creation>2025-04-19T13:11:12.563Z</creation></dates><accession>S-EPMC11274467</accession><cross_references><pubmed>39062118</pubmed><doi>10.3390/biomedicines12071545</doi></cross_references></HashMap>